Afinion 2 Analyzer, model #1116986
Recall Z-2736-2024, part of FDA recall event 94910. See Abbott Diagnostics Technologies AS's company page.
Abbott Diagnostics Technologies AS started this Class II device recall on Jun 17, 2024 (voluntary: firm initiated); FDA lists it as ongoing.
- Classification: Class II
- Started: Jun 17, 2024
- Status: Ongoing
Five Afinion 2 (AF2) Analyzer were incorrectly market configured as Moderate Complexity and distributed to customers. Use of moderately complex assays by waived laboratories could result in erroneous results.
- Product
- Afinion 2 Analyzer, model #1116986, US refurbished, CLIA waived.
- Quantity
- 5 analyzers
- Lots and codes
- Lot #433706, Serial numbers AF20008880, AF20002691, AF20035414, AF20015543 and AF20035460; UDI-DI: 07070060014708.
- Distribution
- US Nationwide distribution in the states of AZ, IN, MA, MN, and OH.
- Recalling firm
- Abbott Diagnostics Technologies AS, Oslo, Norway
- How the firm notified
- Letter
- FDA classified
- Aug 27, 2024
Newest first, one product per recall event; search them all
- Power supply provided with Afinion 2, Catalog numbers 1116553, 1116554, 1116556, 1116557, 1116597, 1116598, 1116663,…Z-2192-2020 · Class II · Mar 23, 2020 · Ongoing
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports